华控康泰：同方药业与北京清控订立北京建筑合约 涉资约3367.24万元

Group 1 - The company Huakong Kantech (01312) announced a construction contract for a research and development complex in Beijing [1] - The contract was signed between Tongfang Pharmaceutical, a wholly-owned subsidiary of the company, and Beijing Qingkong [1] - The estimated contract value is approximately RMB 33.67 million, subject to adjustments [1]